Central but not systemic inhibition of inducible nitric oxide synthase modulates oxytocin release during endotoxemic shock

Peptides

Volumn 31, Issue 4, 2010, Pages 706-711

  Stabile, Angelita Maria ^a   Moreto, Viviana ^a   Antunes Rodrigues, José ^a   Carnio, Evelin Capellari ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood pressure; Lipopolysaccharide; Nitric oxide; Oxytocin; Septic shock

Indexed keywords

AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; OXYTOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DECAPITATION; EXPERIMENTAL DESIGN; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; MULTICHANNEL RECORDER; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RADIOIMMUNOASSAY; RAT; SEPTIC SHOCK; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; ENDOTOXEMIA; FEMALE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXYTOCIN; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 77649231391     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.11.004     Document Type: Article

References (42)

1. Batalhão M.E., Moreto V., Stabile A.M., Antunes-Rodrigues J., and Carnio E.C. Role of dexamethasone on vasopressin release during endotoxemic shock. Regul Pept 147 1-3 (2008) 67-71
2. Bredt D.S., and Snyder S.H. Isolation of nitric oxide synthetase, a calmodulim-requiring enzyme. Proc Natl Acad Sci 87 2 (1990) 682-685
3. Brosnan C.F., Lee S.C., and Liu J. Regulation of inducible nitric oxide synthase expression in human glia: implications for inflammatory central nervous system diseases. Biochem Soc Trans 25 (1997) 679-683
4. Carnio E.C., Stabile A.M., Batalhão M.E., Silva J.S., Antunes-Rodrigues J., Branco L.G., et al. Vasopressin release during endotoxaemic shock in mice lacking inducible nitric oxide synthase. Pflugers Arch 450 6 (2005) 390-394
5. Christensen J.D., Hansen W.E., and Fjalland B. Influence of interleukin-1-beta on secretion of oxytocin and vasopressin from the isolated rat neurohypophysis. Pharmacol Toxicol 67 (1990) 81-83
6. Corrêa P.B., Pancoto J.A., de Oliveira-Pelegrin G.R., Cárnio E.C., and Rocha M.J. Participation of iNOS-derived NO in hypothalamic activation and vasopressin release during polymicrobial sepsis. J Neuroimmunol 183 1-2 (2007) 17-25
7. Gillespie A., Brummer H.C., and Chard T. Oxytocin release by infused prostaglandin. Br Med J 26 (1972) 543-554
8. Giusti-Paiva A., Castro M., Antunes-Rodrigues J., and Carnio E.C. Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release septic shock. Crit Care Med 30 (2002) 1306-1310
9. Gutkowska J., Jankowsky M., Lambert C., Mukaddam-Daher S., Zingg H.H., and McCann S.M. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci 94 (1997) 11704-11709
10. Hansen E.W., and Chirtensen J.D. Endotoxin and interleukin 1-β induces fever and increased plasma oxytocin in rabbits. Pharmacol Toxicol 70 (1992) 389-391
11. Harada S., Imaki T., and Chikada N. Distinct distribution and time course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus following lipopolisaccharide injection. Brain Res 821 (1999) 322-329
12. Hasan K., Heesen B.J., Corbett J.A., McDaniel M.L., Chang K., Allison W., et al. Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 249 1 (1993) 101-106
13. Kadekaro M., Liu H., Terrell M.L., Gestl S., Bui V., and Summy L.J. Role of NO on vasopressin and oxytocin release and blood pressure response during osmotic stimulation in rats. Am J Physiol 273 (1997) R1024-R1030
14. Kadekaro M., Terrell M.L., Liu H., Gestl S., Bui V., and Summy-Long J.Y. Effects of L-NAME on cerebral metabolic, vasopressin, oxytocin, and blood pressure in haemorrhage rats. Am J Physiol 274 (1998) R1070-R1077
15. Kjaer A., Larsen P.J., Knigge U., and Warberg J. Histaminergic activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 135 (1994) 1171-1177
16. Kjaer U.K., Kristoffersen U., Madsen K., Toftegaard C., Jørgensen H., and Warberg J. Histamine and prostaglandin interaction in regulation of oxytocin and vasopressin secretion. J Neuroendocrinol 15 (2003) 940-945
17. Landry D.W., Levin H.R., Gallant E.M., Seo S., D'Alessandro D., Oz M.C., et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25 (1997) 1279-1282
18. Leib S.L., Kim Y.S., Black S.M., Tureen J.H., and Täuber M.G. Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J Infect Dis 177 (1998) 692-700
19. 1A receptors in the isolated perfused rat kidney. Naunyn Schmiedebergs Arch Pharmacol 363 4 (2001) 369-375
20. Lopez-Belmonte J., and Whittle B.J. Aminoguanidine-provoked leukocyte adherence to rat mesenteric venules: role of constitutive nitric oxide synthase inhibition. Br J Pharmacol 116 6 (1995) 2710-2714
21. Ludwing M., Callahan M.F., Neuman I., Landgraf R., and Morris M. Systemic osmotic stimulation increases vasopressin and oxytocin release within the supraoptic nucleus. J Neuroendocrinol 6 (1994) 369-373
22. Mackler A.M., Ducsay T.C., Ducsay C.A., and Yellon S.M. Effects of endotoxin and macrophage-related cytokines on the contractile activity of the gravid murine uterus. Biol Reprod 69 4 (2003) 1165-1169
23. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Ann Rev Immunol 15 (1997) 323-350
24. Matsunaga W., Miyata S., Takamata A., Bun Hiromitsu, Nakashima T., and Kiyohara T. LPS-induced Fos expression in oxytocin and vasopressin neurons of the rat hypothalamus. Brain Res 858 (2000) 9-18
25. Michelini L.C., Marcelo M.C., Amico J., and Morris M. Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice. Am J Physiol Heart Circ Physiol 284 6 (2003) H2269-H2276
26. Morris M., Lucion A.B., Li P., and Callahan M.F. Central oxytocin mediates stress-induced tachycardia. J Neuroendocrinol 7 (1995) 455-459
27. Murphy S., Simmons M.L., Agullo I., Garcia A., Feinstein D.L., Galea E., et al. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 16 (1993) 323-327
28. Naito Y., Fukuta K., Shindo O., Ebisui N., Murakami T., Tominaga T., et al. Effects of interleukins on plasma oxytocin levels in conscious, freely moving rats. Biochem Biophys Res Commun 174 (1991) 1189-1195
29. Ogetman Z., Dirlik M., Caglikulekci M., Canbaz H., Karabacak T., Yaylak F., et al. The effect of aminoguanidine on blood and tissue lipid peroxidation in jaundiced rats with endotoxemia induced with LPS. J Invest Surg 19 1 (2006) 19-30
30. Parrat J.R. Myocardial and circulatory effects of E. coli endotoxin; modification of response to cathecolamines. Br J Pharmacol 47 (1973) 12-25
31. Parrillo J.E., Parker M.M., Natanson C., Suffredini A.F., Danner R.L., Cunnion R.E., et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113 (1990) 227-242
32. Srisawat R., Ludwig M., Bull P.M., Douglas A.J., Russel J.A., and Leng G. Nitric oxide and oxytocin system in pregnancy. J Neurosci 20 17 (2000) 6721-6727
33. Suffredini A.F., Fromm R.E., Parker M.M., Brenner M., Kovacs J.A., Wesley R.A., et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321 (1989) 280-287
34. Summy-Long J.Y., Bui V., Mantz S., Koehler E., Weisz J., and Kadekaro M. Central inhibition of nitric oxide synthase preferentially augments release of oxytocin during dehydration. Neurosci Lett 152 1-2 (1993) 190-193
35. Summy-Long J.Y., Hu S., Long A., and Phillips T.M. Interleukin-1beta release in the SON area during osmotic stimulation requires neural function. J Neuroendocrinol 20 (2008) 1224-1232
36. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 29 (1997) 159-199
37. Torres-Duenas D., Benjamim C.F., Ferreira S.H., and Cunha F.Q. Failure of neutrophil migration to infectious focus and cardiovascular changes on sepsis in rats: effects of the inhibition of nitric oxide production, removal of infectious focus, and antimicrobial treatment. Shock 25 (2006) 267-276
38. Ventura R.R., Giusti-Paiva A., Gomes D.A., Elias L.L.K., and Antunes-Rodrigues J. Neuronal nitric oxide synthase inhibition differently affects oxytocin and vasopressin secretion in salt loaded rats. Neurosci Lett 379 (2005) 75-80
39. Wendy W.Y., and Krukoff T.L. Nitric oxide regulates body temperature, neuronal activation and interleukin-1 gene expression in the hypothalamic paraventricular nucleus in response to immune stress. Neuropharmacology 39 (2000) 2075-2089
40. Wolff D.J., and Lubeskie A. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophys 316 1 (1995) 290-301
41. Wong M.L., Rettori V., Al-Shekhlee A., Bongiorno P.B., Canteros G., McCann S.M., et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med 2 5 (1996) 581-584
42. Xie X.Q., Shinozawa Y., Sasaki J., Takuma K., Akaishi S., Yamanouchi S., et al. The effects of arginine and selective inducible nitric oxide synthase inhibitor on pathophysiology of sepsis in a CLP model. J Surg Res 146 2 (2008) 298-303